Showing results (111-120 of 392) with videos related to

Sort By:
Pageof 40
Blood|August 12, 2008
Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: results from a detailed genetic characterization with long-term follow-upThorsten Zenz, Alexander Kröber, Katrin Scherer, et al.
Leukemia & Lymphoma|December 10, 2020
No increased bleeding events in patients with relapsed chronic lymphocytic leukemia and indolent non-Hodgkin lymphoma treated with idelalisibJacqueline C Barrientos, Peter Hillmen, Gilles Salles, et al.
Haematologica|March 11, 2021
Clonal evolution in chronic lymphocytic leukemia is scant in relapsed but accelerated in refractory cases after chemo(immune) therapyMarc Zapatka, Eugen Tausch, Selcen Öztürk, et al.
Haematologica|March 4, 2014
Interactions between comorbidity and treatment of chronic lymphocytic leukemia: results of German Chronic Lymphocytic Leukemia Study Group trialsValentin Goede, Paula Cramer, Raymonde Busch, et al.
Blood|October 24, 2002
Genetic analysis of de novo CD5+ diffuse large B-cell lymphomas suggests an origin from a somatically mutated CD5+ progenitor B cellTiemo Katzenberger, Andreas Lohr, Stephan Schwarz, et al.
Cancers|June 16, 2019
Dissecting the Prognostic Significance and Functional Role of Progranulin in Chronic Lymphocytic LeukemiaLena Schulze-Edinghausen, Claudia Dürr, Selcen Öztürk, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2004
Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterationsCarsten Schwaenen, Michelle Nessling, Swen Wessendorf, et al.
British Journal of Haematology|November 15, 2019
TBET-expressing Th1 CD4<sup>+</sup> T cells accumulate in chronic lymphocytic leukaemia without affecting disease progression in Eµ-TCL1 micePhilipp M Roessner, Bola S Hanna, Selcen Öztürk, et al.
Frontiers in Oncology|September 28, 2020
Prolonged Course of COVID-19-Associated Pneumonia in a B-Cell Depleted Patient After RituximabIgor Kos, Benedikt Balensiefer, Sophie Roth, et al.
International Journal of Cancer|February 24, 2015
Epigenetic silencing of miR-708 enhances NF-κB signaling in chronic lymphocytic leukemiaConstance Baer, Christopher C Oakes, Amy S Ruppert, et al.
Pageof 40